SUBSCRIBE
SUBSCRIBE

GlaxoSmithKline

NEWS
AstraZeneca, GSK, Novartis and Roche React to Brexit and Its Possible Impact on Biotech
Policy
AstraZeneca PLC, GlaxoSmithKline, Novartis AG and Roche React to Brexit and Its Possible Impact on Biotech
June 24, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
New York Startup Rgenix Bags $33 Million, Gears Up to Push Drug Once-Shelved by GlaxoSmithKline into Trial
June 15, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Rumors Floating Again that Roche or GlaxoSmithKline Might Acquire Bay Area’s Pacific Biosciences
June 3, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Ionis Pharma Plummets After GlaxoSmithKline Opts Not to Initiate Phase III Study for Amyloid Cardiomyopathy Drug
May 26, 2016
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
Amid Positive First Quarter Financials, GlaxoSmithKline Boss Expects a Late 2016 Replacement
April 27, 2016
 · 
2 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
GlaxoSmithKline May Need To Sweeten the Pot to Lure in A New CEO
April 20, 2016
 · 
4 min read
GlaxoSmithKline Terminates Development of Losmapimod for COPD
Business
GlaxoSmithKline CEO Sir Andrew Witty to Step Down in 2017
March 17, 2016
 · 
3 min read
Two Private Investigators Accuse GlaxoSmithKline of Hiring Them Under False Pretenses
Business
Interview with GlaxoSmithKline’s Possible Successor to CEO Andrew Witty
March 14, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Bad News for Bay Area’s Five Prime as GlaxoSmithKline Walks Away from Cancer Drug Pact
March 11, 2016
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Pharm Country
Pfizer Inc., GlaxoSmithKline, and Siemens Create R&D Consortium With A*STAR’s ICES
June 20, 2013
 · 
5 min read
Business
GlaxoSmithKline Links With French Venture Firm to Target Rare Diseases
June 20, 2013
 · 
1 min read
Deals
GlaxoSmithKline Negotiating $1 Billion Sale of Thrombosis Drugs to Aspen Pharmacare Ltd.
June 19, 2013
 · 
1 min read
Policy
Another GlaxoSmithKline Scandal in China: Bribing Docs to Prescribe Meds?
June 13, 2013
 · 
1 min read
Policy
GlaxoSmithKline’s MS Drug Tests Put on Hold After Fraud Claim
June 13, 2013
 · 
1 min read
Business
GlaxoSmithKline Fires Head of Its Chinese R&D Unit for Data Fraud
June 11, 2013
 · 
1 min read
GlaxoSmithKline’s Avandia Vote Ends an Era of Drug Safety Scandals
June 7, 2013
 · 
1 min read
GlaxoSmithKline Probes Allegedly Fraudulent Data in Study Written by Employees
June 5, 2013
 · 
1 min read
Deals
Aqua Pharmaceuticals Acquires Verdeso® Foam
June 5, 2013
 · 
1 min read
Business
Response Genetics, Inc. Achieves Milestone Payments Totaling $1,000,000 for Services Provided to GlaxoSmithKline in the Development of BRAF-Inhibitor Tafinlar® (dabrafenib)
June 4, 2013
 · 
1 min read
Load More